Cas:98476-27-8 ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate manufacturer & supplier

Chemical Name:ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate

CAS.NO:98476-27-8

Synonyms:5-cyano-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid,ethyl ester;ethyl 1-(4-chlorophenyl)-5-cyano-4-pyrazolecarboxylate,ethyl ester;1-(4-CHLOROPHENYL)-5-CYANO-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER;ethyl 1-(4-chlorophenyl)-5-cyano-1H-pyrazole-4-carboxylate

Molecular Formula:C₁₃H₁₀ClN₃O₂

Molecular Weight:275.69000

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:444.5ºC at 760 mmHg

Density:1.31g/cm3

Index of Refraction:1.613

PSA:67.91000

Exact Mass:275.04600

LogP:2.57408

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-cyano-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid,ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 1-(4-chlorophenyl)-5-cyano-1H-pyrazole-4-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 1-(4-chlorophenyl)-5-cyano-1H-pyrazole-4-carboxylate Use and application,5-cyano-1-(4-chlorophenyl)-1H-pyrazole-4-carboxylic acid,ethyl ester technical grade,usp/ep/jp grade.

Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate manufacturer Physiologically relevant interactions with test molecules or protein ligands can be identified with high sensitivity and specificity. ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate supplier Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate vendor The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. ethyl 1-(4-chlorophenyl)-5-cyanopyrazole-4-carboxylate factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.